Can a Minimum Rate of Investigation of Measleslike Illnesses Serve as a Standard for Evaluating Measles Surveillance?

Journal of Infectious Diseases

Volumn 189, Issue SUPPL. 1, 2004, Pages

  Harpaz, Rafael ^a   Papania, Mark J ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; HEALTH SURVEY; HUMAN; INCIDENCE; INFORMATION PROCESSING; LABORATORY TEST; MEASLES; POPULATION; PRIORITY JOURNAL; RASH; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 2442567937     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/378776     Document Type: Article

References (17)

1. Harpaz R, Papania MJ, McCauley MM, Redd SB. Has surveillance been adequate to detect endemic measles in the United States? J Infect Dis 2004; 189(Suppl 1):191-5.
2. Pan American Health Organization. Report of the Seventh Meeting of the Technical Advisory Group on Expanded Program on Immunizations and Polio Eradication, Cartagena, Columbia, 11-14 July 1989. Washington, DC: PAHO, 1989; publication no. EPI/TAG7/89.
3. de Quadras CA, Hersh BS, Olivé JM, Andrus JK, da Silviera CM, Carrasco PA. Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988-1995. J Infect Dis 1997; 175(suppl 1):S37-42.
4. Andrus JK, de Quadros CA, Olivé JM. The surveillance challenge: final stages of eradication of poliomyelitis in the Americas. MMWR Morb Mortal Wkly Rep 1992; 41(SS-1):21-6.
5. Pan American Health Organization. Strategies for the certification of the eradication of wild poliovirus transmission in the Americas. Bull Pan Am Health Organ 1993; 27:287-96.
6. World Health Organization. Field guide for supplementary activities aimed at achieving polio eradication 1996 revision. Geneva: World Health Organization, 1997; document no. WHO/EPI/GEN/95.01 Rev.1.
7. Kennedy RH, Danielson MA, Mulder DW, Kurland LT. Guillain-Barré syndrome: a 42-year epidemiologic and clinical study. Mayo Clin Proc 1978; 53:93-9.
8. Alter M. The epidemiology of Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S7-12.
9. Olivé JM, Castillo C, Castro RG, de Quadras CA. Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America. J Infect Dis 1997; 175(suppl 1):S160-4.
10. Prevots DR, Sutter RW. Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. J Infect Dis 1997; 175(suppl 1):S151-5.
11. Birmingham ME, Linkins RW, Hull BP, Hull HF. Poliomyelitis surveillance: the compass for eradication. J Infect Dis 1997; 175(suppl 1): S146-50.
12. Andrus JK, de Quadros C, Olivé JM, Hull HF. Screening of cases of acute flaccid paralysis for poliomyelitis eradication: ways to improve specificity. Bull World Health Organ 1992; 70:591-6.
13. Dietz V, Andrus J, Olivé JM, Cochi S, de Quadros C. Epidemiology and clinical characteristics of acute flaccid paralysis associated with non-polio enterovirus isolation: the experience in the Americas. Bull World Health Organ 1995; 73:597-603.
14. De Quadros CA, Andrus JK, Olivé JM, et al. Eradication of poliomyelitis: progress in the Americas. Pediatr Infect Dis J 1991; 10:222-9.
15. Steindel SJ, Rauch WJ, Simon MK, Handsfield J. National Inventory of Clinical Laboratory Testing Services (NICLTS): Development and test distribution for 1996. Arch Pathol Lab Med 2000; 124:1201-8.
16. Nordin JD, Harpaz R, Harper P, Rush W. Syndromic surveillance for measles-like illnesses in a managed care setting. J Infect Dis 2004; 189(Suppl 1):222-7.
17. World Health Organization, Expanded Programme on Immunization. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Geneva: World Health Organization, 1998; document no. WHO/EPI/GEN/98.01.